Alzheimer Disease & Associated Disorders

Papers
(The TQCC of Alzheimer Disease & Associated Disorders is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier14
Rescreening on RBANS Delayed Memory Index? Forget About It!14
A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers14
Meta-Analysis of Animal Fluency Performance in Amnestic Mild Cognitive Impairment and Cognitively Unimpaired Older Adults14
Frequent Occurrence of Alzheimer Disease in Patients With IgE-mediated Allergies13
Asian Cohort for Alzheimer Disease (ACAD) Pilot Study13
Psychometric Evaluation of the Perceived Research Burden Assessment (PeRBA) in Longitudinal Studies of Alzheimer Disease Using Rasch Analysis13
Focusing on Earlier Management of Alzheimer Disease13
Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results12
Effects of Depression on Changes in Cognitive Function in Older Adults11
Alzheimer Disease: A New Beginning in Therapeutics11
Characterization of Balance Control and Postural Stability in Patients With Alzheimer Disease10
Interaction of Alzheimer Disease and Traumatic Brain Injury on Cortical Thickness10
The Technology in Caring Questionnaire10
Triadic Communication in Medical Encounters Including Individuals With Dementia9
Mild Cognitive Impairment Subtype Performance in Comparison to Healthy Older Controls on the NIH Toolbox and Cogstate9
The Impact of Episodes of Lucidity on People Living With Dementia and Their Caregivers9
Risk of Neuropsychiatric Symptoms Among People Who Develop Cognitive Impairment With and Without a History of Post-traumatic Stress Disorder8
Carotid Intima-Media Thickness (cIMT) and Cognitive Performance: A Population-Based Cross-Sectional Study from North India: Erratum8
The Influence of Traffic Lights Presentation of Dementia Risk Screening Information on Older Adults’ Motivations for Risk Reduction in Primary Care Settings8
Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity in the United States8
Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results7
DXA-Measured Abdominal Adipose Depots and Structural Brain Integrity in Postmenopausal Women7
Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression7
Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology7
Recruitment of a Diverse Community-based Older Adult Cohort for a Longitudinal Aging Study7
Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E20276
MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes6
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer6
Compassion Versus Accuracy6
“I′m not a risk taker”6
Hypothesis6
Mapping the Landscape of Those Left Behind When a Person With Dementia Dies6
Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia5
CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies5
An Indian Young-onset Dementia With Parkinsonism With Double Heterozygous Mutations in ABCA7 and PRKN Identified Through Whole-exome Sequencing5
Psychosocial and Behavioral Outcomes for Persons With Cognitive Impairment and Caregivers Following Amyloid-β PET Scan Disclosure5
A New Presenilin-1 Missense Variant Associated With a Progressive Supranuclear Palsy-like Phenotype5
Measurement of Allostatic Load in Caregivers of Older Hispanic People With Alzheimer Disease and Related Disorders5
Meta-Analysis of White Matter Hyperintensity Volume Differences Between APOE ε4 Carriers and Noncarriers5
Feasibility and Acceptability of a Multifaceted Observational Protocol to Investigate Lucidity in Advanced Dementia5
Predictors of Cognitive Change in Parkinson Disease5
Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment5
Evidence of Pericyte Damage in a Cognitively Normal Cohort5
A Delphi Approach to Define Lucid Episodes in People Living With Dementia5
A Pilot Randomized Trial of a Purposeful and Stimulating Volunteer Opportunity5
One Minute of EEG Data Provides Sufficient and Reliable Data for Identifying Lewy Body Dementia5
0.10274004936218